- Home
- AUTL vs BRSP Comparison
AUTL vs BRSP Comparison
Compare AUTL & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- BRSP
- Stock Information
- Founded
- AUTL 2014
- BRSP 2017
- Country
- AUTL United Kingdom
- BRSP United States
- Employees
- AUTL N/A
- BRSP N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- BRSP Real Estate Investment Trusts
- Sector
- AUTL Health Care
- BRSP Real Estate
- Exchange
- AUTL Nasdaq
- BRSP Nasdaq
- Market Cap
- AUTL 625.4M
- BRSP 665.4M
- IPO Year
- AUTL 2018
- BRSP 2018
- Fundamental
- Price
- AUTL $1.75
- BRSP $5.78
- Analyst Decision
- AUTL Strong Buy
- BRSP Buy
- Analyst Count
- AUTL 5
- BRSP 4
- Target Price
- AUTL $9.12
- BRSP $6.38
- AVG Volume (30 Days)
- AUTL 2.7M
- BRSP 788.9K
- Earning Date
- AUTL 08-12-2025
- BRSP 07-29-2025
- Dividend Yield
- AUTL N/A
- BRSP 11.07%
- EPS Growth
- AUTL N/A
- BRSP N/A
- EPS
- AUTL N/A
- BRSP N/A
- Revenue
- AUTL $29,934,000.00
- BRSP $335,107,000.00
- Revenue This Year
- AUTL $472.28
- BRSP N/A
- Revenue Next Year
- AUTL $114.92
- BRSP $9.97
- P/E Ratio
- AUTL N/A
- BRSP N/A
- Revenue Growth
- AUTL 185.17
- BRSP N/A
- 52 Week Low
- AUTL $1.11
- BRSP $4.16
- 52 Week High
- AUTL $5.00
- BRSP $6.45
- Technical
- Relative Strength Index (RSI)
- AUTL 32.10
- BRSP 68.65
- Support Level
- AUTL $1.70
- BRSP $5.49
- Resistance Level
- AUTL $1.89
- BRSP $5.69
- Average True Range (ATR)
- AUTL 0.15
- BRSP 0.13
- MACD
- AUTL -0.06
- BRSP 0.03
- Stochastic Oscillator
- AUTL 11.49
- BRSP 96.51
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.